PHA Final Exam Fall 2001

Similar documents
PHA Second Exam Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA Final Exam Fall 2006

PHA First Exam Fall 2003

PHA First Exam. Fall 2004

PHA 5127 FINAL EXAM FALL On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA Second Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA Second Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA Final Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA Final Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA 4120 Second Exam Key Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA Second Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA Spring First Exam. 8 Aminoglycosides (5 points)

PHA First Exam Fall 2013

PHA 5128 Spring 2000 Final Exam

PHA 5128 Final Exam Spring 2004 Version A. On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA 5128 Spring 2009 First Exam (Version B)

BASIC PHARMACOKINETICS

Pharmacokinetics Overview

BIOPHARMACEUTICS and CLINICAL PHARMACY

1. If the MTC is 100 ng/ml and the MEC is 0.12 ng/ml, which of the following dosing regimen(s) are in the therapeutic window?

Multiple IV Bolus Dose Administration

Name: UFID: PHA Exam 2. Spring 2013

General Principles of Pharmacology and Toxicology

Drug Dosing in Renal Insufficiency. Coralie Therese D. Dimacali, MD College of Medicine University of the Philippines Manila

Nontraditional PharmD Program PRDO 7700 Pharmacokinetics Review Self-Assessment

Thus, we can group the entire loading dose together as though it was given as a single dose, all administered when the first dose was given.

. Although there is a little

TDM. Measurement techniques used to determine cyclosporine level include:

PHA 5128 CASE STUDY 5 (Digoxin, Cyclosporine, and Methotrexate) Spring 2007

PHA5128 Dose Optimization II Case Study I Spring 2013

TDM of Aminoglycoside Antibiotics

Basic Pharmacokinetic Principles Stephen P. Roush, Pharm.D. Clinical Coordinator, Department of Pharmacy

PHAR 7633 Chapter 20 Non Compartmental Analysis

C OBJECTIVES. Basic Pharmacokinetics LESSON. After completing Lesson 2, you should be able to:

LD = (Vd x Cp)/F (Vd x Cp)/F MD = (Css x CL x T)/F DR = (Css x (Vm-DR))/Km Css = (F x D)/(CL x T) (Km x DR)/(Vm DR)

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

Basic Pharmacokinetics and Pharmacodynamics: An Integrated Textbook with Computer Simulations

PHA5128 Dose Optimization II Case Study 3 Spring 2013

PHA 5128 Case Study 4 (Answers) Total Cp = Unbound Cp/fu.

TDM Lecture 7 5 th Stage. TDM of Digoxin. Uses: Digoxin is usually used in heart failure associated and atrial fibrillation.

PHARMACOKINETICS SMALL GROUP II:

ICU Volume 11 - Issue 3 - Autumn Series

The general Concepts of Pharmacokinetics

Basic Concepts of TDM

Osnove farmakokinetike. Aleš Mrhar. Prirejeno po. A First Course in Pharmacokinetics and Biopharmaceutics by David Bourne,

Introduction to Pharmacokinetics (PK) Anson K. Abraham, Ph.D. Associate Principal Scientist, PPDM- QP2 Merck & Co. Inc., West Point, PA 5- June- 2017

Tamer Barakat. Abdul Aziz ALShamali. Abdul Aziz ALShamali

Pharmacokinetics in Drug Development. Edward P. Acosta, PharmD Professor & Director Division of Clinical Pharmacology Director, CCC PK/PD Core

Applied Biopharmaceutics & Pharmacokinetics Sixth Edition

Pharmacokinetics PCTH 325. Dr. Shabbits September 12, C t = C 0 e -kt. Learning Objectives

DMPK. APRIL 27 TH 2017 Jan Neelissen Scientific Adviser Science & Technology

Pharmacokinetics of drug infusions

Understand the physiological determinants of extent and rate of absorption

PHARMACOKINETICS SMALL GROUP I:

Pharmacokinetics of Drugs. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

Carbamazepine has a clearance of L/h/kg for monotherapy. For immediate release carbamazepine, the oral bioavailbility is 0.8

TDM of Digoxin. Use of Digoxin Serum Concentrations to Alter Dosages

Introduction to. Pharmacokinetics. University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

Principal Investigator: Marion, Alan, S, M.D., MDS Pharma Services (US) Inc., 621 Rose Street, PO Box 80837, Lincoln, NE 68502, USA

Nonlinear Pharmacokinetics

Pharmacokinetics One- compartment Open Model Lec:2

Pharmacokinetic parameters: Halflife

Basic pharmacokinetics. Frédérique Servin APHP hôpital Bichat Paris, FRANCE

Case Study 2 Answers Spring 2006

ADME Review. Dr. Joe Ritter Associate Professor of Pharmacology

Determination of bioavailability

Tutorial. & In case studies 1 and 2, we explore intravenous iv. & Then, we move on to extravascular dosing in case

Biomath M263 Clinical Pharmacology

Biopharmaceutics Lecture-11 & 12. Pharmacokinetics of oral absorption

Policy: Created: 2/11/2015; Approved: Adult Pharmacokinetic Dosing and Monitoring- Vancomycin Dosing

Aminoglycosides. Uses: Treatment of serious gram-negative systemic infections and some grampositive

CLINICAL PHARMACOKINETICS INDEPENDENT LEARNING MODULE

Adjusting phenytoin dosage in complex patients: how to win friends and influence patient outcomes

Metformin Associated Lactic Acidosis. Jun-Ki Park 9/6/11

Drug dosing in Extremes of Weight

Renal Function. 1. Glomerular filtration 2. Active tubular secretion 3. Passive tubular reabsorption 4. Excretion

SHC Vancomycin Dosing Guide

General Principles of Pharmacology and Toxicology

Problem Set for Fundamentals 9 Oct 2013

One-Compartment Open Model: Intravenous Bolus Administration:

USES OF PHARMACOKINETICS

Take-Home Exam Distributed: October 19, 2012, at 2:30 p.m. Due: October 24, 2012, at 1:30 p.m.

Flecainide pharmacokinetics in healthy volunteers: the influence of urinary ph

Pharmacokinetics I. Dr. M.Mothilal Assistant professor

WHY INTRAMUSCULAR METHOTREXATE MAY BE MORE EFFICACIOUS THAN ORAL DOSING IN PATIENTS WITH RHEUMATOID ARTHRITIS

PHA Case Studies V (Answers)

Pharmacokinetics for Physicians. Assoc Prof. Noel E. Cranswick Clinical Pharmacologist Royal Children s Hospital Melbourne

POPULATION PHARMACOKINETICS RAYMOND MILLER, D.Sc. Daiichi Sankyo Pharma Development

Introduction to. Pharmacokinetics. University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

COMPARTMENTAL ANALYSIS OF DRUG DISTRIBUTION Juan J.L. Lertora, M.D., Ph.D. Director Clinical Pharmacology Program September 23, 2010

Renal Excretion of Drugs

Uncommon Indications for Extracorporeal Toxin Removal (ECTR) Robert S. Hoffman, MD Director, Division of Medical Toxicology NYU School of Medicine

Excretion of Drugs. Prof. Hanan Hagar Pharmacology Unit Medical College

The clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only.

PHAR 7632 Chapter 16

IV Vancomycin dosing and monitoring Antibiotic Guidelines. Contents. Intro

(Max 2 g) = to nearest 250 mg

prophylaxis for endocarditis in patients at high risk prophylaxis for major surgical procedures

Click to edit Master title style

Transcription:

PHA 5127 Final Exam Fall 2001 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Question/Points 1. /12 pts 2. /8 pts 3. /12 pts 4. /20 pts 5. /27 pts 6. /15 pts 7. /20 pts 8. /25 pts 9. /15 pts 10. /6 pts 11. /5 Bonus pts TOTAL /160 (out 165 possible) 1

1.) Mark the following statements as True or False (12 points) T F Decreasing dosing interval (τ) will cause steady-state to be reached faster. T F Increasing plasma protein binding will decrease the volume of distribution. T F The absorption rate constant (k a ) is always larger than the elimination rate constant (k e ). T F Route of administration (e.g., i.v., i.m., p.o.) will affect the AUC (assume bioavailability is 100% for all routes). T F The maximum value of renal clearance is greater than the maximum value of hepatic clearance. T F Loading doses are mainly given for drugs with long half-lives. 2

2.) Which graph(s) best depicts a two-compartment body model drug? (8 points) A B Ln(C p ) Ln(C p ) C Time D Time Ln(C p ) Ln(C p ) Time Time Answer(s): 3

3.) With more people exercising, the question arises, does exercise alter the pharmacokinetics of drugs? Using the following information, answer the proceeding questions. (12 points) Table 1 : Changes in blood flow during exercise according to intensity of exercise. Blood Flow (ml min -1 ) Tissue Rest Light Exercise Moderate Exercise Intense Exercise Liver 1500 1100 600 300 Muscle 1000 4500 12500 22000 Kidney 1100 900 600 250 Based on Table 1, answer the following questions A. Circle the correct answer. Intense exercise would change the hepatic clearance of a: High Extraction Drug Low Extraction Drug Both a High and Low Extraction Drug Exercise would have no effect. B. Fill in the blank. Intense exercise would the extraction ratio of a low extraction drug? a) Increase b) Decrease c) Not Change C. Fill in the blank. Intense exercise would the bioavailability of a high extraction drug? a) Increase b) Decrease c) Not Change D. Fill in the blank. Intense exercise would the onset of action of a lipophilic muscle relaxant. a) Shorten b) Lengthen c) Not Change 4

4.) Mr. D. Johnson from the University of Miami, needs to gain weight for his upcoming lead-role in The Scorpion King. His physician, Dr. Adam, puts Mr. Johnson (Rocky to his friends) on the oral anabolic steroid, Dianabol, 5 mg every 6 hours. Dianabol has the following pharmacokinetic parameters: V D = 100 L, k a = 1 h -1, t 1/2 = 3 h, and bioavailability is 80%. Assume first order kinetics. (20 points) A. What is the AUC for a single dosing interval at steady-state? B. What is the average steady-state concentration? 5

4 cont d.) Mr. Johnson decides he doesn t like oral anabolic steroid due to their side effects. Dr. Adam prescribes the intramuscular steroid Deca-Durabolin which is administered once a day. The terminal half-life of this drug after intramuscular injection is much longer than if it was given as an iv. bolus. C. Explain the differences in terminal half-life between the 2 routes of administration. D. Can this explain the once a day dosing regiment? 6

5.) A 26 year-old white male, AMP, is admitted to the emergency room with a ruptured appendix. Before surgery (even though AMP had no health insurance), you are asked to begin this patient on a new antibiotic. (Assume 1-compartment body model). (27 points) Useful Information Drug is predominately eliminated by kidney AMP is 5 10, 70 kg and a creatinine clearance (CrCL) of 89 ml min -1 V D =0.25 L kg -1 Population estimate of K e = 0.00321*(CrCL in ml min -1 )+0.014 (k e is in h -1 ) Based on the Population estimate of K e, AMP is start of the following dosing schedule K 0 = 1000 mg h -1 Dosing interval (τ) = 6 hours Infusion time (T) = 1h Desired steady state plasma range: 60 mg L -1 to 12 mg L -1 Blood samples are taken during the first dose to verify proper dosing schedule was calculated-: > Cp 1 hour after stop of infusion = 36.5 mg L -1. > Cp 3 hour after stop of infusion = 20 mg L -1. A. Calculate the half-life for this drug in AMP. Do you think the dosing schedule needs to be readjusted for Adam based on his value and the expected population estimate? 7

5 cont d.) B. Is the desired C MAX at steady state (60 mg L -1 ) being obtained in AMP? C. Suppose (at steady state), the nurse starts the infusion an hour late. What will be the plasma levels when the infusion is started? 8

6.) The following concentration time profiles were observed after multiple i.v. bolus injections of a drug. The two curves differ in one of the input parameters (Dose, CL, Vd ). (15 points) Original Identify the input parameter that differs. Explain your reasoning in one or two sentences. What is the numeric value of this parameter? 9

7.) Consider the following equation. (20 points) Cp Dose k e = e k Volume (1 e 1 e ) a) What does this equation describe? b) What do the blocked parts of the equation represent? Dose Volume 1 (1 e ) k e e k e τ 10

8.) Due to the stress of finals, the entire 2PD class comes down with the flu and students are admitted to Shands Hospital. All the students are to be given an antiviral therapy by IV infusion (continuous constant rate infusion, not multiple short term infusions). The average population t 1/2 is 2 h, the average V D is 80 L, and the effective plasma concentration is 15 mg L -1. (25points) A. Recommend an infusion rate in milligrams per hour to reach the steady state concentration of 15 mg L -1. B. Approximately how long will it take to reach this concentration? 11

8 cont d.) One student, J.R., does not seem to respond to therapy. Plasma protein binding for the drug is normally 20% (f u =0.8) except in J.R. whose protein binding was 40% (f u = 0.6). Tissue binding is similar to the rest of the class C. (Circle best answer) A possible reason why J.R. is not responding to therapy is: A. The drug is a high extraction drug and lowering f u will increase clearance and plasma levels will become sub-therapeutic B. The drug is a low extraction drug and lowering f u will increase clearance and plasma levels will become sub-therapeutic. C. The drug is a high extraction drug. Clearance will not change but here is less free-drug caused by increased protein binding and it is free-drug that is active. D. The drug is a high extraction drug. Clearance will be increased and the total and free drug levels will be decreased. D. (Circle the best answer) The volume of distribution in JR is LARGER THAN / SMALLER THAN / THE SAME AS the rest of the class. E. (Circle the best answer) To achieve the same free plasma steady-state concentrations, the daily dose in JR should be LARGER THAN / SMALLER THAN / THE SAME AS the rest of the class. 12

9.) Fill in the blank with the most appropriate answer. (15 points) A. is the name of the mathematical technique used to separate and calculate the absorption rate constant (k a ) from a concentrationtime profile. B. Drugs that are unionized and can cross membranes easily. C. To increase the renal clearance of an acidic drug that is ionizable, you would want to the ph of the urine. D. Drugs like ethanol follow -order elimination because a constant amount of ethanol is eliminated in a given time. E. In pharmacokinetics,, is a measure of the activity of hepatic enzymes. 13

10.) What is the differential equation describing the change in drug concentration after an i.v. bolus administration for a one-compartment body model drug. (assume first order kinetics). (6 points) 11) Today (Dec 12 th ) is an extremely important day because (5 Bonus points) A. It is the last day the 2PD class has finals B. It is the eve of Frank Sinatra s birthday C. Only 13 days till Christmas (or the third day of Hanukkah) D. It is Dr. Hochhaus and Adam s birthday (age 21 and 16, respectively). E. All the above F. None of the above 14